In the 1990s and early 2000s, there was a lively history of science scene in Ireland. However since then, this area of study has been greatly neglected. Queen’s University History of Science ...

Patient-level digital twins expected to strengthen evidence generation in Phase1/2 clinical study evaluating VTx-002, a first-in-class vectorized antibody targeting TDP-43 pathology in patients with ...

VectorY Therapeutics Announces First Participant Dosed in Phase 1/2 PIONEER-ALS Clinical Trial of VTx-002 in People with Amyotrophic Lateral Sclerosis (ALS) VTx-002 is a first-in-class vectorized ...

Learn how to determine the vector magnetic field of two parallel wires with this comprehensive physics guide! 🧲⚡ This step-by-step tutorial explains the principles of magnetic fields, current ...

Sophie Germain was a brilliant, self-taught mathematician who won one of France's most prestigious prizes, yet she declined to attend the award ceremony because the committee members didn't respect ...

Physics Problem: Solving vector operations step-by-step! ️📐 In this video, we break down how to perform vector operations, such as addition, subtraction, and scalar multiplication, with real-world ...

The Helen Edwards Engineering Research Center is designed to act as a collaborative space for scientists and engineers. (Courtesy: Ryan Postel, Fermilab) Construction of the Helen Edwards Engineering ...

AMSTERDAM & BOSTON--(BUSINESS WIRE)--VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) ...

At the upper end of the price band, the IPO will value the company at INR 31,169 Cr (about $3.5 Bn) The IPO comprises a fresh issue of up to INR 3,100 Cr and an offer for sale (OFS) of up to INR 380 ...

NASDAQ-Listed Company Adds Two Distinguished Advisors with Complementary Expertise The strategic advisor additions strengthen RET's leadership capabilities as the Company progresses toward deployment ...